Meijuan Fang
8PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Nov 17, 2025
Structure-Based Design and Optimization of Bi-Aryl Amide Derivatives as Nur77 Ligands for Nur77-Bcl-2-Dependent Apoptotic Cancer Therapy.Taige Zhao, Jun Chen, Wenbin Hong
|Nov 20, 2023
Discovery of 5-(Pyrimidin-2-ylamino)-1H-indole-2-carboxamide Derivatives as Nur77 Modulators with Selective and Potent Activity Against Triple-Negative Breast Cancer.Jingbo Qin, Boning Niu, Xiaohui Chen
|Oct 26, 2023
The novel CDK9 inhibitor, XPW1, alone and in combination with BRD4 inhibitor JQ1, for the treatment of clear cell renal cell carcinoma.Zhijian Kuang, Kaiqiang Guo, Yin Cao
|Jun 26, 2023
Design, synthesis, and evaluation of novel benzoylhydrazone derivatives as Nur77 modulators with potent antitumor activity against hepatocellular carcinoma.Fengming He, Jun Chen, Taige Zhao
|May 11, 2022
Design, synthesis, and biological evaluation of AV6 derivatives as novel dual reactivators of latent HIV-1.Mingtao Ao, Zhenrui Pan, Yuqing Qian
|May 06, 2022
Insights into the stereoselectivity of human SETD7 methyltransferase.Bowen Tang, Baicun Li, Boqun Li
Pageof 2
